Notice: This company has been marked as potentially delisted and may not be actively trading. Medicis Pharmaceutical (MRX) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesOptions ChainTrends Get the Latest News and Ratings for MRX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Medicis Pharmaceutical and its competitors. Enter your email to sign up for newsletter Sign Up MRX Analyst Ratings Over TimeTypeCurrent Forecast11/17/23 to 11/16/241 Month Ago10/18/23 to 10/17/243 Months Ago8/19/23 to 8/18/241 Year Ago11/17/22 to 11/17/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s) N/A Buy7 Buy rating(s)7 Buy rating(s)7 Buy rating(s) N/A Hold0 Hold rating(s)0 Hold rating(s)0 Hold rating(s) N/A Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s) N/A Consensus Price Target$30.71$27.00$26.71N/AForecasted Upside8.38% Upside5.59% Upside12.24% UpsideN/AConsensus RatingBuyBuyBuyN/A Ever heard of this 8-day bitcoin profit window? (Ad)Did you know Bitcoin almost always soars higher during an 8-Day Profit Window? Most people have no clue… But for over a year now, some of our top students have had the chance to cash in with some incredible gains during this 8-day window.It’s coming up quick. MRX Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History MRX Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Medicis Pharmaceutical Stock vs. The CompetitionTypeMedicis PharmaceuticalFinance CompaniesS&P 500Consensus Rating Score 3.00 2.49 2.50Consensus RatingBuyHoldModerate BuyPredicted Upside8.38% Upside12.12% Upside9.85% UpsideNews Sentiment RatingNeutral NewsSee Recent MRX NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails11/8/2024Barclays3 of 5 stars Boost TargetOverweight ➝ Overweight$30.00 ➝ $32.00+12.52%11/8/2024Keefe, Bruyette & Woods4 of 5 starsK. VoigtSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOutperform ➝ Outperform$30.00 ➝ $33.00+16.03%11/8/2024Piper Sandler2 of 5 starsP. MoleySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$30.00 ➝ $32.00+12.52%11/6/2024CitigroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Buy$34.00+24.77%5/20/2024The Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageBuy$33.00+72.96%5/20/2024UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageBuy$27.00+41.51%5/20/2024Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageBuy$24.00+25.79%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:32 PM ET. MRX Forecast - Frequently Asked Questions What is Medicis Pharmaceutical's forecast for 2025? According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for Medicis Pharmaceutical is $30.71, with a high forecast of $34.00 and a low forecast of $24.00. Should I buy or sell Medicis Pharmaceutical stock right now? 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medicis Pharmaceutical in the last year. There are currently 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MRX shares. Does Medicis Pharmaceutical's stock price have much upside? According to analysts, Medicis Pharmaceutical's stock has a predicted upside of 8.38% based on their 12-month stock forecasts. What analysts cover Medicis Pharmaceutical? Medicis Pharmaceutical has been rated by research analysts at Barclays, Citigroup, Keefe, Bruyette & Woods, and Piper Sandler in the past 90 days. Do Wall Street analysts like Medicis Pharmaceutical more than its competitors? Analysts like Medicis Pharmaceutical more than other "finance" companies. The consensus rating for Medicis Pharmaceutical is Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MRX compares to other companies. Stock Forecasts and Research Tools Related Companies Forge Global Stock Forecast Intercontinental Exchange Stock Forecast CME Group Stock Forecast Nasdaq Stock Forecast Tradeweb Markets Stock Forecast T. Rowe Price Group Stock Forecast LPL Financial Stock Forecast Wintrust Financial Stock Forecast Jackson Financial Stock Forecast AGNC Investment Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter 📉 Warning: Market Crash Predicted - Secure Your Savings (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Take these 4 steps to protect your retirement here >>> This page (NYSE:MRX) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicis Pharmaceutical Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicis Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRX Stock Alerts